Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 29.99%74.84M | 18.86%69.5M | -12.32%57.33M | -3.96%236.33M | 55.4M | 57.58M | 58.47M | 65.38M | 4.17%246.08M | 6.20%236.23M |
| Cost of revenue | 39.54%60.95M | 18.07%55.71M | -15.30%44.89M | -3.67%188.24M | 44.59M | 43.68M | 47.18M | 53M | 8.69%195.41M | 5.59%179.78M |
| Gross profit | -0.01%13.9M | 22.16%13.8M | 0.44%12.44M | -5.09%48.1M | 10.81M | 13.9M | 11.29M | 12.39M | -10.23%50.67M | 8.21%56.45M |
| Operating expense | -40.06%5.71M | -24.30%5.57M | -3.78%6.59M | 40.28%25.66M | 2.32M | 9.52M | 7.36M | 6.85M | 11.46%18.29M | 7.45%16.41M |
| Selling and administrative expenses | -31.09%8.76M | 5.23%9.02M | 3.14%8.88M | 15.80%36.54M | --7.04M | --12.71M | --8.57M | --8.61M | 6.65%31.56M | 21.62%29.59M |
| -General and administrative expense | -31.09%8.76M | 5.23%9.02M | 3.14%8.88M | 15.80%36.54M | --7.04M | --12.71M | --8.57M | --8.61M | 6.65%31.56M | 21.62%29.59M |
| Total other operating income | -4.30%3.05M | 184.64%3.45M | 30.04%2.29M | -17.94%10.89M | --4.72M | --3.19M | --1.21M | --1.76M | 0.66%13.27M | 45.49%13.18M |
| Operating profit | 87.07%8.19M | 109.02%8.23M | 5.66%5.85M | -30.71%22.44M | 8.49M | 4.38M | 3.94M | 5.53M | -19.13%32.38M | 8.52%40.04M |
| Net non-operating interest income (expenses) | -7.86%-1.81M | 1.39%-1.78M | 3.41%-1.64M | -4.48%-7.03M | -1.85M | -1.68M | -1.8M | -1.7M | -22.89%-6.73M | -23.63%-5.48M |
| Non-operating interest expense | 7.86%1.81M | -1.39%1.78M | -3.41%1.64M | 4.48%7.03M | --1.85M | --1.68M | --1.8M | --1.7M | 22.89%6.73M | 23.63%5.48M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -940K | -538K | 0 | -37.46%-1.82M | -1.82M | 0 | 0 | 0 | -19.03%-1.32M | 61.22%-1.11M |
| Less:Write off | --940K | --538K | --0 | 37.46%1.82M | --1.82M | --0 | --0 | --0 | 19.03%1.32M | -61.22%1.11M |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 101.56%5.44M | 177.20%5.91M | 9.68%4.2M | -44.15%13.59M | 4.82M | 2.7M | 2.13M | 3.83M | -27.27%24.33M | 13.01%33.45M |
| Income tax | -8.68%1.12M | 190.01%1.95M | 35.89%1.58M | -11.50%5.91M | 2.86M | 1.22M | 671K | 1.16M | -32.81%6.68M | 108.73%9.94M |
| Net income | 192.63%4.33M | 171.32%3.96M | -1.68%2.63M | -56.51%7.68M | 1.96M | 1.48M | 1.46M | 2.67M | -24.93%17.65M | -5.35%23.51M |
| Net income continuous operations | 192.63%4.33M | 171.32%3.96M | -1.68%2.63M | -56.51%7.68M | --1.96M | --1.48M | --1.46M | --2.67M | -24.93%17.65M | -5.35%23.51M |
| Noncontrolling interests | 0 | 0 | ||||||||
| Net income attributable to the company | 192.63%4.33M | 171.32%3.96M | -1.68%2.63M | -56.51%7.68M | 1.96M | 1.48M | 1.46M | 2.67M | -24.93%17.65M | -5.35%23.51M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 192.63%4.33M | 171.32%3.96M | -1.68%2.63M | -56.51%7.68M | 1.96M | 1.48M | 1.46M | 2.67M | -24.93%17.65M | -5.35%23.51M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 200.00%0.0042 | 173.68%0.0039 | -0.27%0.0026 | -35.52%0.0111 | 0.0019 | 0.0014 | 0.0014 | 0.0026 | -24.93%0.0172 | -5.35%0.0229 |
| Diluted earnings per share | 200.00%0.0042 | 173.68%0.0039 | -0.27%0.0026 | -35.52%0.0111 | 0.0019 | 0.0014 | 0.0014 | 0.0026 | -24.93%0.0172 | -5.35%0.0229 |
| Dividend per share | ||||||||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.